Bocouture (1x50iu)

Bocouture

Bocouture is a medicine that contains the active substance Botulinum toxin type A. This relaxes the muscles, it improves upper facial lines in adults under 65 years of age.

It has been available in the U.K. since 2008. As the brand name Xeomin in the UK for blepharospasm and cervical dystonia.

In July 2010 it gained approval for cosmetic use. And it is marketed for this indication, with dosing specific to treat glabellar (frown) lines,  under the brand name Bocouture.

Bocouture claims to be an innovative Botulinum type A formulation. In which the complexing proteins are removed by an extensive purification process from the botulinum toxin complex. In contrast to the other commercially available preparations. Bocouture contains the pure 150 kD neurotoxin.

The bacterial protein present in other products plays a role as promoters of an immune reaction. Resulting in a loss of effect and reduction in the duration of the activity. Studies show that Bocouture, without the complex proteins, has the lowest content of protein of all of the available botulinum toxins. This shows that continuous application of Bocouture, even in high doses, does not induce the formation of neutralizing antibodies.

Meaning that Bocouture can provide similar results to those achievable with the other products without the risk of antibody formation, providing continual long-lasting effects. This could be relevant when large doses are being used for medical indications. But many industry experts question the relevance when this product is used for cosmetic purposes.

How does Bocouture work

Like Botox and the alternative injectable products for wrinkle relaxing. Bocouture being a Botulinum Toxin is a natural, but highly purified protein. It facilitates the relaxing of muscles, thus softening wrinkles and facial lines. Thus allowing the signs of facial aging to be reduced to create a younger look.

Bocouture before and after use

The bacterial protein present in other products plays a role as promoters of an immune reaction. Resulting in a loss of effect and reduction in the duration of the activity. Studies show that Bocouture, without the complex proteins, has the lowest content of protein of all of the available botulinum toxins. This shows that continuous application of Bocouture, even in high doses, does not induce the formation of neutralizing antibodies.

Meaning that Bocouture can provide similar results to those achievable with the other products without the risk of antibody formation, providing continual long-lasting effects. This could be relevant when large doses are being used for medical indications

How long does Bocouture last?

A Bocouture wrinkle relaxing injection treatment lasts on average for 3-4 months; this may be longer in some individuals.